PEGylation of Interferon-β-1a: A Promising Strategy in Multiple Sclerosis

ISSN： 1172-7047

Source： CNS Drugs, Vol.26, Iss.3, 2012-03, pp. : 205-214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interferon-β_1b for the treatment of multiple sclerosis

By Lam Sum Wang Shan Gottesman Malcolm

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 8, 2008-08 ,pp. : 1111-1117

Informa Healthcare

Access to resources Recommend Favorite

Interferon-β_1b in the treatment of multiple sclerosis

By Río Jordi Montalban Xavier

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 16, 2005-12 ,pp. : 2877-2886

Informa Healthcare

Access to resources Recommend Favorite

Interferon-β-1b: A Review of its Use in Multiple Sclerosis

By Plosker Greg L.

CNS Drugs, Vol. 25, Iss. 1, 2011-01 ,pp. : 67-88

Adis International

Access to resources Recommend Favorite

Interferon-β-1b of benefit in early multiple sclerosis

Inpharma, Vol. 1, Iss. 1512, 2005-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Interferon-β-1b: In Newly Emerging Multiple Sclerosis

By McKeage Kate

CNS Drugs, Vol. 22, Iss. 9, 2008-01 ,pp. : 787-792

Adis International

Access to resources Recommend Favorite